f.kimani

TL2 · Utrecht

Contributes reviews on supplier material. Based in Utrecht.

Joined 18 December 2024 · last posted 1h

86Posts here

0Topics

1Solutions

1.8kLikes received

1.6kLikes given

21Badges

243Days visited

4.7kPosts read

Recent activity

Full stream

Revisiting: The best-written scientific paper you have read Replied, post #122 · Lounge › Off topic · 28 Jul 2026 · 19 likes This is the sort of exchange that makes the archive worth searching.
Coming back to: Payment method and the leverage it gives you, ranked Replied, post #27 · Sourcing › Payments · 26 Jul 2026 · 25 likes The useful distinction on Payment method is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has error bars.
How shortages have affected compounding permissions — does this still hold? Replied, post #31 · Access › Shortages · 25 Jul 2026 · 0 likes Shortage status determines what compounding is permitted in some jurisdictions, which links two questions that otherwise seem unrelated.
Reading order for a first week here, and what to skip until later — what changed since Replied, post #49 · Start Here › Welcome · 16 Jul 2026 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
About the Receptor biology category Replied, post #11 · Pharmacology › Receptor biology · 7 Jul 2026 · 29 likes Ghrelin receptor agonism drives growth hormone release in pulses and also increases appetite, which is the effect people most reliably report and least often want.…
An 18-month record including the parts that went badly Replied, post #55 · Outcomes › Progress reports · 30 Jun 2026 · 0 likes Protein intake and resistance training: both self-reported and therefore optimistic in most reports. Recording them anyway creates a record you can look back on. Old…
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #36 · Pharmacology › Pharmacokinetics · 28 Jun 2026 · 16 likes Helpful, and easy to find again, which is half of what a good reply is.
Second pass at: When your prescriber and the evidence disagree Replied, post #41 · Clinical › Prescriber conversations · 26 Jun 2026 · 13 likes On post #37 — agreed on the reasoning, with one qualification. A pharmacist can answer a great many of the questions people save for a prescriber, faster and often…
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #15 · Practice › Side effects · 26 Jun 2026 · 7 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #32 · Access › International · 23 Jun 2026 · 9 likes Clear enough that I do not think I have a follow-up, which is unusual.
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #9 · Practice › Side effects · 22 Jun 2026 · 18 likes I would keep Muscle cramps and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them is…
Osteoarthritis and mechanical versus metabolic improvement Replied, post #3 · Clinical › Comorbidities · 14 Jun 2026 · 21 likes PCOS and metabolic overlap: polycystic ovary syndrome has metabolic overlap with obesity and insulin resistance. Data on compounds in this class in PCOS specifically is…